Aripiprazole in a patient vulnerable to side effects [1]

American Journal of Psychiatry

Volumn 162, Issue 3, 2005, Pages 625-

  Dehning, Sandra ^a   Riedel, Michael ^a   Müller, Norbert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; NEUROLEPTIC AGENT; PIMOZIDE; SULPIRIDE; TIAPRIDE; ZIPRASIDONE;

ADULT; AMENORRHEA; CASE REPORT; CHRONIC DISEASE; FEMALE; GALACTORRHEA; GILLES DE LA TOURETTE SYNDROME; HUMAN; LETTER; PRIORITY JOURNAL; SIDE EFFECT; TIC; TREATMENT OUTCOME;

EID: 14844322354     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.3.625     Document Type: Letter

References (5)

1. Müller N, Riedel M, Zawta P, Günther W, Sträube A: Comorbidity of Tourette's syndrome and schizophrenia: biological and physiological parallels. Progr Neuropsychopharmacol Biol Psychiatry 2002; 26:1245-1252
2. Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 1997; 154: 1057-1062
3. Robertson MM, Schnieden V, Lees AJ: Management of Gilles de la Tourette syndrome-using sulpiride. Clin Neuropharmacol 1990; 13:229-235
4. Sallee FR, Kurlan R, Goetz CH, Singer H, Scahill L, Law G, Dittman VL, Chappell PB: Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000; 39:292-299
5. McGavin JK, Goa KL: Aripiprazole. CNS Drugs 2002; 16:779-786